Jennifer S. Mammen

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider et al. · Journal of Clinical Oncology · 2018 · 3.7K citations · Full text

Life Sciences, Immunology, Oncology +17

The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis

Karthik Suresh, Jarushka Naidoo, Qiong Zhong et al. · Journal of Clinical Investigation · 2019 · 198 citations · Full text

Life Sciences, Immunology, Pathology +17

EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes

Hong Yin, Yunbo Li, Jennifer S. Mammen et al. · Proceedings of the National Academy of Sciences · 2009 · 98 citations · Full text

Life Sciences, Dermatology, Molecular Biology +13

Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging

Jennifer S. Mammen, John McGready, Rachael Oxman et al. · Thyroid · 2015 · 93 citations · Full text

Medicine, Endocrinology, Geriatric Medicine +12

Single amino acid mutations, but not common polymorphisms, decrease the activity of CYP1B1 against (-)benzo[a]pyrene-7R-trans-7,8-dihydrodiol

Jennifer S. Mammen, Gary S. Pittman, Yulong Li et al. · Carcinogenesis · 2003 · 37 citations · Full text

Medicine, Genetics, Molecular Genetics +17